Ocular Therapeutix to Present New Data on Sustained Release Drug Candidates Utilizing Proprietary Hydrogel Technology at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

Autor:	Ocular Therapeutix, Inc.
Zdroj:	Business Wire (English). 04/28/2014.
Abstrakt:	Ocular Therapeutix, Inc. , which is developing sustained release ophthalmic drug products using a proprietary hydrogel technology, has announced six posters will be presented at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in taking place at the Orange County Convention Center in Orlando, Florida, from May 4-8, 2014. [ABSTRACT FROM PUBLISHER]
Databáze:	Regional Business News
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.